No Data
GMO Research & AI: Q3 Financial Results Q&A Collection for the Fiscal Year Ending December 2024
GMO Research & AI --- Sales to domestic research companies and global panel companies improved in the third quarter, with continued improvement expected in the fourth quarter overall.
GMO Research & AI <3695> announced its consolidated financial results for the third quarter of the fiscal year ending December 2024 (January-September 24). Revenue decreased by 3.8% year-on-year to 3.657 billion yen (an increase of 3.6% excluding the impact of special factors until 2Q), operating profit decreased by 75.7% to 0.073 billion yen, ordinary profit decreased by 78.3% to 0.067 billion yen, and net profit attributable to the parent company's shareholders for the quarter decreased by 73.1% to 0.058 billion yen. Regarding sales revenue by sales channel, to domestic business companies.
Stocks that moved the previous day part2: Serendip, GMO TECH, Moriya Trucking Industry, etc.
Stock Name <Code> 7-day closing price ⇒ day-on-day comparison Osaka Titanium Technologies <5726> 2028 -189 Performance estimates are downward revised due to Boeing's strike. Colopl <3668> 487 -45 The previous period is expected to fall into an operating deficit. Minebea Mitsumi <6479> 2675.5 -182.5 Full year net profit estimate has been downward revised. Sansan <4443> 2164 -155 Weakened by the rise in long-term U.S. interest rates in the small and medium-sized growth sector. M3 <2413>
Active and newly listed stocks during the morning session.
*Maiko <6787> 6600 Ka - upward revision of performance and dividends forecast. *Net One <7518> 4305 Ka - aligning with the SCSK's TOB price of 4500 yen. *Coca-Cola BJI <2579> 2266 +323 Large-scale share buyback announcement is well received. *Keio Electric Railway <9008> 3915 +559 Announced upward revision of performance and dividends forecast and share buyback. *Sigma Xis <6088> 1909 +241 Evaluation of upward revision of performance and dividend increase. *Digital HD
Supported by a firm US stock market, but there may be a heavy resistance to price increases.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a firm development. In the U.S. stock market on the 6th, the Dow Jones increased significantly by $1,508.05 (+3.57%) to $43,729.93, with uncertainties dispelled by the passing of the presidential election. Expectations for the policies of the second Trump administration and anticipation for additional rate cuts at the Federal Open Market Committee (FOMC) supported stock prices. Today's emerging markets are likely to see a dominant buying trend. This occurred due to significant rises in major indices in the U.S. stock market yesterday.
GMO broadcasting, MTG and others
<3690> Ilgurum increased dividends, with the previous period's dividend per share at 7.80 yen ← 7.60 yen <3695> GMO-R&Ai downward revision, operating profit outlook for the current period 0.264 billion yen ← 0.502 billion yen <4258> Amai upward revision, operating profit outlook for the current period 0.459 billion yen ← 0.419 billion yen <6180> GMO broadcasting upward revision, operating profit outlook for the current period 0.715 billion yen ← 0.65 billion yen, increased dividends, with the current period's dividend per share at 174.00 yen ← 121.00 yen (including exceeding the 5-year plan and listing 10).
No Data
No Data